HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xu Chen Selected Research

Polypyrimidine Tract-Binding Protein

3/2021Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].
1/2021Erratum: Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM.
1/2019Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
1/2017Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xu Chen Research Topics

Disease

168Neoplasms (Cancer)
12/2022 - 06/2008
39Inflammation (Inflammations)
06/2022 - 07/2012
32Breast Neoplasms (Breast Cancer)
04/2022 - 05/2012
29Infections
01/2022 - 02/2005
24Neoplasm Metastasis (Metastasis)
12/2022 - 02/2013
20Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2012
18Atrial Fibrillation
06/2022 - 03/2004
16Carcinogenesis
01/2022 - 01/2013
15Lymphatic Metastasis
01/2022 - 01/2014
15Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2015
13Prostatic Neoplasms (Prostate Cancer)
05/2022 - 01/2013
12Stomach Neoplasms (Stomach Cancer)
08/2022 - 01/2009
11Pain (Aches)
12/2022 - 01/2008
11Necrosis
12/2022 - 01/2011
11Hypoxia (Hypoxemia)
11/2022 - 01/2016
11Wounds and Injuries (Trauma)
10/2022 - 02/2005
11Insulin Resistance
03/2022 - 01/2015
11Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2014
10Heart Failure
12/2022 - 03/2015
10Lung Neoplasms (Lung Cancer)
03/2022 - 08/2011
10COVID-19
01/2022 - 01/2020
10Carcinoma (Carcinomatosis)
01/2022 - 05/2009
10Hypertension (High Blood Pressure)
01/2021 - 02/2012
9Fibrosis (Cirrhosis)
12/2022 - 09/2009
9Non-alcoholic Fatty Liver Disease
03/2022 - 01/2017
9Myocardial Infarction
03/2022 - 01/2016
9Renal Cell Carcinoma (Grawitz Tumor)
06/2021 - 03/2014
8Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 07/2010
8Obesity
01/2022 - 06/2018
8Bacterial Infections (Bacterial Infection)
01/2022 - 10/2017
8Atherosclerosis
01/2022 - 01/2014
8Nasopharyngeal Carcinoma
12/2021 - 07/2011
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 10/2010
8Ischemia
01/2020 - 07/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 08/2011
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 06/2015
7Glioma (Gliomas)
01/2022 - 01/2013
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 09/2017
6Cardiac Arrhythmias (Arrythmia)
01/2022 - 06/2014
6Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2017
6Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 07/2013
6Cataract (Cataracts)
08/2021 - 05/2010
6Stroke (Strokes)
01/2020 - 08/2009
6Burns
11/2019 - 03/2002
5Lung Injury
06/2022 - 06/2013
5Infarction (Infarctions)
04/2022 - 01/2011
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
04/2022 - 04/2019
5Periodontitis
01/2022 - 09/2014
5Hypertrophy
12/2021 - 05/2014
5Rheumatoid Arthritis
07/2021 - 06/2018

Drug/Important Bio-Agent (IBA)

60Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2010
38Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2013
33Pharmaceutical PreparationsIBA
06/2022 - 04/2011
29MicroRNAs (MicroRNA)IBA
01/2022 - 02/2013
24Biological ProductsIBA
01/2022 - 03/2011
20Glucose (Dextrose)FDA LinkGeneric
09/2022 - 11/2009
19Messenger RNA (mRNA)IBA
01/2022 - 08/2014
13CytokinesIBA
06/2022 - 02/2012
13Small Interfering RNA (siRNA)IBA
01/2022 - 09/2008
13ORALIT (ORS)IBA
01/2020 - 01/2013
12Interleukin-6 (Interleukin 6)IBA
12/2022 - 01/2009
12Therapeutic UsesIBA
04/2022 - 03/2013
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2009
11Triglycerides (Triacylglycerol)IBA
03/2022 - 01/2017
11Long Noncoding RNAIBA
03/2022 - 01/2017
11curcumolIBA
01/2022 - 07/2011
11CateninsIBA
01/2022 - 07/2010
10Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 01/2016
9LipidsIBA
01/2022 - 01/2017
8EnzymesIBA
12/2022 - 05/2018
8Peptides (Polypeptides)IBA
01/2021 - 01/2017
7VaccinesIBA
04/2022 - 10/2016
7RNA (Ribonucleic Acid)IBA
03/2022 - 01/2019
7Angiotensin IIIBA
01/2021 - 02/2012
61-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2022 - 10/2016
6LipopolysaccharidesIBA
05/2022 - 01/2015
6Circular RNAIBA
01/2022 - 01/2019
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 04/2012
6Immune Checkpoint InhibitorsIBA
01/2022 - 11/2019
6Phosphotransferases (Kinase)IBA
04/2021 - 06/2008
5Interleukin-18 (Interleukin 18)IBA
06/2022 - 11/2016
5LDL CholesterolIBA
03/2022 - 10/2016
5Blood Glucose (Blood Sugar)IBA
01/2022 - 11/2014
5C-Reactive ProteinIBA
01/2022 - 01/2009
5Oxygen (Dioxygen)IBA
01/2022 - 12/2018
5Aurora Kinase AIBA
01/2022 - 08/2016
5Interleukin-17 (Interleukin 17)IBA
01/2022 - 09/2014
5OvalbuminIBA
01/2022 - 02/2018
5RutheniumIBA
09/2021 - 10/2017
5Antiviral Agents (Antivirals)IBA
07/2021 - 09/2008

Therapy/Procedure

65Therapeutics
12/2022 - 11/2006
20Catheter Ablation
01/2022 - 03/2004
12Lasers (Laser)
12/2022 - 02/2005
12Drug Therapy (Chemotherapy)
01/2022 - 01/2008
10Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2022 - 02/2005
9Immunotherapy
04/2022 - 01/2019
8Photothermal Therapy
04/2022 - 01/2018
7Photochemotherapy (Photodynamic Therapy)
11/2022 - 03/2017
7Transplantation
01/2020 - 01/2013
5Radiotherapy
11/2022 - 09/2016